Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liver toxicity of sitaxentan in pulmonary arterial hypertension.
Galiè N, Hoeper MM, Gibbs JS, Simonneau G. Galiè N, et al. Among authors: simonneau g. Eur Respir J. 2011 Feb;37(2):475-6. doi: 10.1183/09031936.00194810. Eur Respir J. 2011. PMID: 21282816 Free article. No abstract available.
Guidelines for the diagnosis and treatment of pulmonary hypertension.
Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT); Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), et al. Among authors: simonneau g. Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12. Eur Respir J. 2009. PMID: 19749199 Free article. No abstract available.
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, Humbert M, Rainisio M, Rubin LJ, Simonneau G. Sitbon O, et al. Among authors: simonneau g. Thorax. 2005 Dec;60(12):1025-30. doi: 10.1136/thx.2005.040618. Epub 2005 Jul 29. Thorax. 2005. PMID: 16055621 Free PMC article.
Management of severe pulmonary arterial hypertension.
Vachiéry JL, Simonneau G. Vachiéry JL, et al. Among authors: simonneau g. Eur Respir Rev. 2010 Dec;19(118):279-87. doi: 10.1183/09059180.00008010. Eur Respir Rev. 2010. PMID: 21119186 Free PMC article. Review.
637 results